Jeff co-founded Silversmith Capital Partners in 2015. At Silversmith, Jeff focuses on investments across the firm’s two core verticals, SaaS & Information Services and Healthcare IT & Services. He currently serves on the Board of Directors of Panalgo, Iodine Software, LifeStance Health, MediQuant, Nordic Consulting, Partners Surgical, and Upperline Health. In addition, he is a Board Observer at Sound Physicians. Jeff spent 14 years as a growth equity investor prior to co-founding Silversmith Capital Partners. Jeff joined Bain Capital Ventures in 2002, where he served as Managing Director from 2009-2014. While at Bain Capital Ventures, Jeff focused predominantly on growth equity investments in the healthcare and technology sectors, with a particular emphasis on healthcare IT, healthcare services, and technology-enabled business services. Prior to Bain Capital Ventures, Jeff worked in Bain Capital’s Private Equity group from 1998-2000, where he focused on technology and healthcare investments. From 1995-1998, Jeff was a consultant at Bain & Company. Some of Jeff’s past investment experience includes ABILITY Network (acquired by Inovalon), Accelecare (acquired by Healogics), Boston Heart Diagnostics (acquired by Eurofins Scientific), Enclarity (acquired by LexisNexis), Liberty Dialysis (acquired by Fresenius Medical Care), MedeAnalytics (acquired by Thoma Bravo), MedHOK (acquired by Hearst), and National Cardiovascular Partners (acquired by Fresenius Medical Care). He received an AB, magna cum laude, in Government and Mathematics from Dartmouth College and an MBA with Distinction from Harvard Business School. Jeff lives with his wife and two children in Belmont, MA. Jeff loves playing most sports, particularly with his kids, and is an avid cyclist. Jeff annually rides the Pan-Mass Challenge, a 192 mile bike ride across Massachusetts, to help raise funds for the Dana-Farber Cancer Institute.